BioAge Labs, Inc. (BIOA) Institutional Ownership

Ownership Summary

BioAge Labs, Inc. (NASDAQ:BIOA) has 109 institutional investors that have filed 13F reports for the period ending December 2025.

• Collectively, these holders controlled 66.0% of BioAge Labs's outstanding shares in December 2025, up from 59.5% in September 2025.
• They increased total shares held in BioAge Labs by 22.87% from last quarter, and the number of investors in BIOA increased 65.15% annually.
• Activity in BIOA broke down as 65 buyers, 23 sellers, and 21 unchanged among 109 total holders.
• Combined, these investors held 23.66Mn shares in BIOA for December 2025, up by 4.4Mn shares quarter on quarter, and up 3.57Mn shares year over year.
• As of December 31, 2025, the biggest holder of BioAge Labs is a16z Capital Management, L.L.C. at 3.23Mn shares, representing 9.02% of shares outstanding.
• Leading buyers of BioAge Labs shares for the quarter ending December 2025 were Octagon Capital Advisors LP (1.6Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.05Mn), COSMIC MANAGEMENT, LLC (501.83K), Janus Henderson Group Plc (409.21K), DIADEMA PARTNERS LP (271.16K).
• Leading sellers of BioAge Labs shares for the quarter ending December 2025 were ADAR1 Capital Management, LLC (1.61Mn), VANGUARD GROUP INC (236.48K), Stonepine Capital Management, LLC (143.57K), RENAISSANCE TECHNOLOGIES LLC (124.6K), Cormorant Asset Management, LP (100.0K).
• Per Business Quant, the top 10 investors in BIOA for the quarter ending December 2025 include a16z Capital Management, L.L.C. (3.23Mn), Sofinnova Investments, Inc. (2.29Mn), Cormorant Asset Management, LP (2.04Mn), Octagon Capital Advisors LP (1.6Mn), BlackRock, Inc. (1.53Mn), VANGUARD GROUP INC (1.41Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.05Mn), ORBIMED ADVISORS LLC (790.9K), Sands Capital Alternatives, LLC (786.35K), Pivotal bioVenture Partners Investment Advisor LLC (653.37K).